Sarcio

Sarcio Inc. is focused on regenerative medicine, specifically targeting osteoarthritis through innovative therapies derived from induced pluripotent stem cells (iPSCs). The company aims to restore joint function and delay or eliminate the need for joint-replacement surgery.